Recombinant Bacteroides forsythus 60 kDa chaperonin (groL), partial

What is Bacteroides forsythus 60 kDa chaperonin (groL) and what is its significance in research?

Bacteroides forsythus (now renamed Tannerella forsythia) 60 kDa chaperonin, also known as GroEL or HSP60, is a heat shock protein that functions as a molecular chaperone in this gram-negative anaerobic bacterium associated with human periodontal disease. The gene specifying this protein was isolated through PCR amplification using consensus primers based on published nucleotide sequences of groEL genes from several bacterial species . Translation of the gene sequence reveals a protein of 544 amino acids with a molecular mass of approximately 58 kDa .

This chaperonin is significant in research for several reasons:

• It represents an immunodominant antigen that can elicit strong and protective immune responses

• It demonstrates evolutionary conservation with homology to other bacterial species (50-81% identity) and human mitochondrial P1 protein

• It plays crucial roles in protein folding, maintaining proteostasis, and stress response

• It may contribute to bacterial virulence and host-pathogen interactions in periodontal disease

How is the B. forsythus groEL gene structurally characterized?

The B. forsythus groEL gene has been characterized through molecular cloning and sequencing techniques. The gene was isolated using PCR-based methods with consensus primers targeting conserved regions of bacterial groEL genes . Structural characterization reveals:

• Complete nucleotide sequence encoding a 544-amino acid protein

• Predicted molecular mass of 58 kDa, though it often appears larger (~60 kDa) on SDS-PAGE due to post-translational modifications

• Significant sequence homology with other bacterial groEL genes (50-81%)

• Conservation of functional domains typical of the HSP60/GroEL family

• Presence of regions responsible for ATP binding and hydrolysis

• Domains involved in substrate protein binding

For molecular studies, the gene can be amplified from B. forsythus genomic DNA using techniques similar to those employed for other B. forsythus genes, such as partial digestion with restriction enzymes like ApoI, followed by cloning into suitable vectors .

What experimental models are appropriate for studying B. forsythus GroEL function?

When investigating B. forsythus GroEL function, researchers can employ several experimental models:

In vitro protein folding systems:

• Purified recombinant GroEL/GroES complexes

• Denatured substrate proteins to assess chaperone activity

• ATP-dependent folding assays

Heterologous expression systems:

• E. coli expression systems using vectors like pGEX for GST-fusion proteins

• IPTG-inducible promoters for controlled expression

Cell culture models:

• Human gingival fibroblasts or epithelial cells to study host-pathogen interactions

• Immune cell lines to investigate immunomodulatory effects

Animal models:

• Murine periodontitis models

• Rat oral infection models

For growth of B. forsythus itself, specialized media conditions are required:

• Brain heart infusion broth containing 5-μg/ml hemin, 0.5-μg/ml menadione, 0.001% N-acetylmuramic acid, and 5% fetal bovine serum

• Anaerobic conditions (85% N₂, 10% H₂, 5% CO₂)

These models allow for comprehensive investigation of GroEL's functional roles in both bacterial physiology and host-pathogen interactions.

How does B. forsythus GroEL compare to other bacterial chaperonins?

B. forsythus GroEL shares significant similarities with other bacterial chaperonins while displaying species-specific characteristics:

Sequence homology:

• Demonstrates 50-81% identity with GroEL proteins of several bacterial species

• Shows evolutionary conservation of functional domains

Structural comparison:

• Like other prokaryotic GroEL proteins, likely forms a double-ring barrel structure

• Requires co-chaperone (GroES/HSP10) for complete functionality

• Contains ATP binding and hydrolysis domains

Functional similarities:

• Primary role in protein folding and prevention of aggregation

• ATP-dependent conformational changes that facilitate substrate folding

• Heat-inducible expression

Unique features:

• Specific immunogenic epitopes that may contribute to periodontal disease pathogenesis

• Potential role in B. forsythus adherence to host tissues

This comparative table highlights key similarities and differences:

How does B. forsythus GroEL interact with the human immune system?

B. forsythus GroEL, as an immunodominant bacterial antigen, engages with the human immune system through multiple mechanisms:

Innate immune recognition:

• Recognition by pattern recognition receptors (PRRs) including TLRs, particularly TLR2 and TLR4

• Activation of innate immune cells including macrophages and dendritic cells

• Induction of pro-inflammatory cytokine production (IL-1β, IL-6, TNF-α)

Adaptive immune responses:

• Processing and presentation by antigen-presenting cells

• Stimulation of B cell responses and antibody production

• Research has demonstrated that adult patients with B. forsythus-associated periodontitis express specific antibodies against bacterial proteins

• T cell recognition and activation, primarily Th1 and Th17 responses

Molecular mimicry and autoimmunity:

• Sequence homology with human mitochondrial HSP60 (P1 protein)

• Potential cross-reactivity of anti-bacterial GroEL antibodies with human HSP60

• Possible contribution to autoimmune aspects of periodontal disease

Immunomodulatory effects:

• Potential alteration of host immune signaling pathways

• Influence on resolution of inflammation and tissue homeostasis

When studying these interactions experimentally, researchers should employ techniques such as:

• ELISAs to measure antibody responses

• Cytokine profiling of immune cells exposed to recombinant GroEL

• T cell proliferation assays

• Flow cytometry to assess immune cell activation

• Immunohistochemistry of periodontal tissue samples

What is the role of B. forsythus GroEL in bacterial stress response and virulence?

GroEL plays multifaceted roles in bacterial stress response and virulence mechanisms:

Stress response functions:

• Protection of essential proteins during environmental stress (temperature, pH, oxidative)

• Refolding of partially denatured proteins to maintain bacterial viability

• Regulation of protein homeostasis during host colonization

• Similar to other HSP60 family members, likely involved in managing oxidative stress responses

Virulence-associated functions:

• Potential contribution to biofilm formation in periodontal pockets

• Possible role in adherence to host tissues or extracellular matrix components

• B. forsythus produces multiple virulence factors, including a trypsin-like protease, sialidase, prtH-encoded protease, and cell surface-associated BspA protein

• May facilitate bacterial adaptation to the inflammatory periodontal environment

Moonlighting functions outside the cell:

• Potential extracellular functions when released from bacteria

• Possible immunomodulatory effects distinct from classical chaperone role

• Interaction with host cell receptors and signaling pathways

• May contribute to bacterial adhesion and invasion processes

Experimental approaches to investigate these roles include:

• Gene knockout studies using recently developed gene inactivation systems for B. forsythus

• Stress response assays under various environmental conditions

• Bacterial adherence and invasion assays with host cells

• Analysis of biofilm formation with wild-type vs. GroEL-deficient bacteria

How do researchers interpret contradictory findings about B. forsythus GroEL function?

Contradictory findings regarding B. forsythus GroEL function require systematic interpretation strategies:

Source validation and strain differences:

• Verify bacterial strain identity (ATCC 43037 is a common reference strain)

• Consider strain-to-strain variations in gene expression and protein function

• Sequence verification of the groEL gene in experimental strains

Methodological reconciliation:

• Analyze differences in experimental conditions (temperature, pH, media composition)

• Assess protein preparation methods (native vs. recombinant, purification techniques)

• Consider tag effects (His-tag, GST-fusion) on protein function and interactions

• Examine differences in assay systems (in vitro vs. cell-based vs. in vivo)

Contextual interpretation:

• Consider microenvironmental factors that may affect protein function

• Evaluate the presence of cofactors and co-chaperones (GroES/HSP10)

• Assess ATP dependency of observed functions

Integrative analysis:

• Develop conceptual models that accommodate seemingly contradictory findings

• Consider multiple functional roles under different conditions

• Use comparative studies with other bacterial GroEL proteins

• Implement multi-omics approaches (transcriptomics, proteomics, interactomics)

When faced with contradictory findings, researchers should systematically document:

• Experimental conditions in detail

• Strain and clone verification data

• Protein preparation and characterization methods

• Controls employed and their results

• Limitations of each experimental approach

This systematic approach allows for more robust interpretation of seemingly conflicting results and development of refined hypotheses for further investigation.

What techniques are optimal for cloning and expressing recombinant B. forsythus GroEL?

Based on successful approaches with other B. forsythus proteins, optimal techniques include:

DNA extraction and gene amplification:

• Genomic DNA isolation using specialized kits (e.g., Qiagen Tip 100)

• PCR amplification using consensus primers based on conserved groEL sequences

• Optimization of PCR conditions for high GC content in B. forsythus DNA

Cloning strategies:

• Partial digestion of genomic DNA with restriction enzymes like ApoI

• Size selection of DNA fragments (2-7 kb range)

• Cloning into expression vectors such as Lambda ZAP II or pGEX

• E. coli strain selection (XL1-BlueMRF' has been successful)

Expression optimization:

• IPTG-inducible promoter systems with optimal concentration of 1.0 mM IPTG

• Expression temperature optimization (typically 25-30°C for improved folding)

• Expression time optimization (2-4 hours post-induction)

• Consider codon optimization for E. coli expression

Protein purification:

• Addition of protease inhibitors (phenylmethylsulfonyl fluoride)

• Cell lysis optimization (sonication parameters: 30s has been effective)

• Affinity chromatography (GST-fusion, His-tag approaches)

• Size exclusion chromatography for final purification

Functional verification:

• SDS-PAGE and Western blot analysis

• In vitro chaperone activity assays

• ATP binding and hydrolysis assays

• Co-immunoprecipitation with potential substrate proteins

These methodologies have been successfully applied to other B. forsythus proteins and can be adapted specifically for GroEL expression and purification.

How can gene knockout techniques be used to study B. forsythus GroEL?

Gene knockout studies provide crucial insights into GroEL function in B. forsythus. Recent developments have made this approach feasible:

Gene inactivation system:

• A gene inactivation system has been successfully developed for B. forsythus, as demonstrated with the bspA gene

• This represents the first reported specific gene knockout in this organism

Methodological approaches:

• Target gene selection:

  • Identification of the groEL gene sequence

  • Analysis of potential polar effects on downstream genes

• Knockout construct design:

  • Creation of constructs with antibiotic resistance cassettes

  • Inclusion of homologous flanking regions for targeted recombination

  • Consideration of partial vs. complete gene deletion strategies

• Transformation methods:

  • Electroporation protocols optimized for B. forsythus

  • Selection on appropriate antibiotic-containing media

  • Screening for successful transformants

• Verification of knockout:

  • PCR verification of gene disruption

  • RT-PCR or qPCR to confirm absence of transcript

  • Western blot analysis to confirm absence of protein

  • Complementation studies to confirm phenotype specificity

Phenotypic analysis of ΔgroEL mutants:

• Growth characteristics under normal and stress conditions

• Protein expression profiles via proteomic analysis

• Virulence assessment in cell culture and animal models

• Comparison with wild-type in adherence, invasion, and biofilm formation assays

The established gene inactivation system for B. forsythus provides a valuable tool for understanding GroEL function through knockout studies, complementing in vitro approaches with recombinant protein .

What purification methods yield the highest purity of recombinant B. forsythus GroEL?

To achieve high-purity recombinant B. forsythus GroEL, a multi-step purification strategy is recommended:

Expression system optimization:

• Selection of appropriate fusion tags (His6, GST, or MBP)

• Codon optimization for E. coli expression

• Low-temperature expression (16-25°C) to enhance solubility

• IPTG concentration optimization (1.0 mM has been effective for other B. forsythus proteins)

Initial capture and purification:

• Affinity chromatography:

  • For GST-fusion proteins: Glutathione Sepharose affinity chromatography

  • For His-tagged proteins: Immobilized metal affinity chromatography (IMAC)

  • Stringent washing with optimized buffer compositions

  • Tag removal via protease cleavage (thrombin for GST-fusion proteins)

• Ion exchange chromatography:

  • Anion exchange (e.g., Q Sepharose) at pH 8.0

  • Salt gradient elution for selective removal of contaminants

  • Collection and analysis of fractions by SDS-PAGE

Polishing steps:

• Size exclusion chromatography:

  • Separation based on molecular size

  • Assessment of oligomeric state (GroEL typically forms tetradecamers)

  • Buffer exchange to final storage buffer

• Hydrophobic interaction chromatography (optional):

  • Further removal of host cell protein contaminants

  • Particularly useful for removing endotoxins

Quality control assessments:

• SDS-PAGE with Coomassie staining (>95% purity)

• Western blot with anti-GroEL antibodies

• Dynamic light scattering to assess aggregation state

• Endotoxin testing (critical for immunological studies)

• Functional assays (ATP binding, substrate protein folding)

Stability optimization:

• Addition of glycerol (10-20%) to prevent aggregation

• Inclusion of reducing agents (DTT or β-mercaptoethanol)

• Determination of optimal pH and ionic strength

• Storage in small aliquots at -80°C

This multi-step purification approach, based on successful strategies for other B. forsythus proteins, maximizes purity while maintaining native conformation and functional activity.

How do you analyze the chaperone activity of recombinant B. forsythus GroEL?

Analysis of B. forsythus GroEL chaperone activity requires carefully designed assays that evaluate its ability to prevent protein aggregation and facilitate proper folding:

Prevention of aggregation assays:

• Light scattering assays:

  • Monitor aggregation of model substrates (citrate synthase, malate dehydrogenase) at elevated temperatures

  • Measure light scattering at 320-360 nm over time

  • Compare aggregation kinetics with and without GroEL

  • Include controls with other chaperones (e.g., E. coli GroEL) for comparison

• Thermal denaturation protection:

  • Assess protection of enzyme activity after thermal stress

  • Measure residual activity of model enzymes with/without GroEL

  • Quantify protection as percentage of original activity retained

Protein folding assays:

• Refolding yield measurement:

  • Denaturation of substrate proteins in guanidinium chloride or urea

  • Dilution into refolding buffer containing GroEL ± GroES and ATP

  • Quantify recovery of enzymatic activity over time

  • Calculate folding yield and kinetics

• Conformational state analysis:

  • Intrinsic fluorescence spectroscopy to monitor structural changes

  • ANS binding to assess exposure of hydrophobic surfaces

  • Circular dichroism to examine secondary structure recovery

ATP hydrolysis coupling:

• ATPase activity measurement:

  • Colorimetric assays for inorganic phosphate release

  • Coupled enzyme assays (pyruvate kinase/lactate dehydrogenase)

  • Correlation of ATP hydrolysis with folding activity

• Nucleotide binding studies:

  • Fluorescence-based nucleotide binding assays

  • Isothermal titration calorimetry

  • Analysis of binding affinity and stoichiometry

Complex formation analysis:

• GroEL-substrate interactions:

  • Co-immunoprecipitation with substrate proteins

  • Surface plasmon resonance for binding kinetics

  • Native PAGE to visualize complex formation

• GroEL-GroES interactions:

  • Size exclusion chromatography to isolate complexes

  • Negative stain electron microscopy to visualize complex formation

  • FRET-based assays for real-time interaction dynamics

These methodological approaches provide comprehensive analysis of chaperone function, allowing comparison with other bacterial GroEL proteins and assessment of factors affecting activity.

How do you design control experiments when studying B. forsythus GroEL immunomodulatory effects?

Rigorous control experiments are essential when investigating the immunomodulatory effects of B. forsythus GroEL:

Protein preparation controls:

• Endotoxin contamination:

  • Limulus amebocyte lysate (LAL) testing of protein preparations

  • Parallel testing with polymyxin B to neutralize potential LPS effects

  • Heat-inactivated GroEL controls (structural integrity lost, endotoxin remains active)

• Protein specificity controls:

  • Irrelevant proteins purified using identical methods

  • Other B. forsythus proteins prepared similarly

  • GroEL proteins from non-periodontal pathogens

  • Mutant GroEL variants with altered functional domains

Cellular response controls:

• Dose-response relationships:

  • Titration of GroEL concentrations (0.1-10 μg/ml range)

  • Establishment of EC50 values for different responses

  • Time-course experiments to distinguish primary from secondary effects

• Cell type specificity:

  • Comparison of responses across multiple cell types

  • Inclusion of cells lacking specific pattern recognition receptors

  • Blocking antibody experiments targeting potential receptors

Signaling pathway validation:

• Inhibitor controls:

  • Specific inhibitors of suspected signaling pathways

  • siRNA knockdown of pathway components

  • Cells from knockout mice lacking specific pathway components

• Pathway activation markers:

  • Phosphorylation state analysis of signaling intermediates

  • Nuclear translocation of transcription factors

  • Reporter gene assays for pathway-specific transcriptional activation

In vivo relevance controls:

• Physiological concentration range:

  • Determination of GroEL levels in periodontal lesions

  • Comparison of in vitro concentrations with in vivo levels

  • Correlation of effects with disease severity

• Patient sample validation:

  • Neutralization of patient-derived samples with anti-GroEL antibodies

  • Comparison of responses in healthy vs. periodontitis patients

  • Genetic association studies for relevant immune receptors

These control experiments ensure that observed immunomodulatory effects are specifically attributable to B. forsythus GroEL rather than contaminants or experimental artifacts.

What statistical approaches are appropriate for analyzing B. forsythus GroEL binding data?

Equilibrium binding analysis:

• Model selection:

  • One-site vs. multiple-site binding models

  • Cooperative vs. non-cooperative binding models

  • Comparison of models using Akaike Information Criterion (AIC) or F-test

• Parameter estimation:

  • Non-linear regression for Kd determination

  • 95% confidence intervals for binding parameters

  • Bootstrap analysis for parameter distribution

Kinetic binding analysis:

• Association/dissociation rate constants:

  • Global fitting of association and dissociation phases

  • Comparison of observed rates across experimental conditions

  • Residual analysis to assess goodness of fit

• Mechanism discrimination:

  • Comparison of simple vs. complex binding mechanisms

  • Statistical tests for mechanism selection (F-test, AIC)

  • Concentration dependence of observed rates

Comparative binding studies:

• Multiple ligand comparison:

  • Two-way ANOVA with post-hoc tests for comparing binding to different substrates

  • Multiple comparison correction (Bonferroni, Holm-Sidak, or FDR)

  • Effect size calculation (Cohen's d or eta-squared)

• Structure-activity relationships:

  • Correlation analysis between structural parameters and binding affinity

  • Multiple regression for multivariate structure-activity models

  • Principal component analysis for complex structure-activity datasets

Thermodynamic parameter analysis:

• Enthalpy-entropy compensation:

  • Linear regression of ΔH vs. TΔS

  • Statistical testing of compensation phenomenon

  • Confidence ellipses for thermodynamic parameters

• Temperature dependence:

  • van't Hoff analysis with appropriate error propagation

  • Testing linearity of ln(K) vs. 1/T plots

  • Heat capacity change determination and statistical validation

Reporting standards:

• Clear definition of binding models used

• Explicit statement of null hypothesis and significance level

• Reporting of sample sizes, degrees of freedom, and exact p-values

• Inclusion of confidence intervals for all estimated parameters

• Graphical presentation of residuals and distribution of errors

These statistical approaches ensure robust analysis of binding data, enabling valid comparisons between B. forsythus GroEL and other molecular chaperones or between wild-type and mutant variants.

How can B. forsythus GroEL be targeted for therapeutic interventions in periodontal disease?

B. forsythus GroEL represents a promising therapeutic target for periodontal disease intervention through multiple strategies:

Vaccine development:

• Subunit vaccines using recombinant GroEL or immunogenic epitopes

• DNA vaccines encoding modified GroEL sequences

• Mucosal adjuvant systems for local immune enhancement

• Selection of epitopes that avoid cross-reactivity with human HSP60

Inhibitor design:

• High-throughput screening for small molecule inhibitors of GroEL function

• Structure-based design targeting ATP binding pocket or substrate interaction sites

• Peptide inhibitors that disrupt GroEL-substrate interactions

• Allosteric modulators affecting conformational changes

Immunomodulatory approaches:

• Neutralizing antibodies against extracellular GroEL

• Targeting of inflammatory pathways activated by GroEL

• Tolerization strategies to reduce autoimmune aspects

• Combination with conventional periodontal treatments

Delivery strategies:

• Local delivery systems (gels, films, nanoparticles)

• Controlled release formulations for sustained effect

• Periodontal pocket insertion devices

• Biofilm-penetrating delivery technologies

Diagnostic-therapeutic integration:

• GroEL-based diagnostic tools to guide personalized treatment

• Monitoring GroEL levels as treatment response markers

• Combination diagnostics for multiple bacterial virulence factors

Research and development considerations should include:

• Rigorous assessment of cross-reactivity with human HSP60

• Evaluation of effects on beneficial oral microbiota

• Integration with existing periodontal treatment modalities

• Long-term safety and efficacy studies in appropriate animal models

These therapeutic approaches leverage our understanding of B. forsythus GroEL biology while addressing the complex nature of periodontal disease pathogenesis.

How might CRISPR-Cas9 technology enhance research on B. forsythus GroEL?

CRISPR-Cas9 technology offers transformative potential for B. forsythus GroEL research, building upon established gene inactivation systems :

Genome editing applications:

• Precise gene modifications:

  • Introduction of point mutations to study structure-function relationships

  • Domain deletions to investigate functional regions

  • Epitope tagging for improved detection and localization

  • Promoter modifications to control expression levels

• Conditional knockouts:

  • Inducible CRISPR systems for temporal control of gene expression

  • Tissue-specific promoters for spatial regulation in animal models

  • Degron-based approaches for rapid protein depletion

High-throughput functional genomics:

• CRISPR screening:

  • Genome-wide screens for genes affecting GroEL function

  • Identification of genetic interactions and functional networks

  • Discovery of bacterial factors modulating GroEL expression

  • Screening for host factors interacting with bacterial GroEL

• Base editing applications:

  • Targeted C-to-T or A-to-G conversions without double-strand breaks

  • Systematic codon substitutions to study amino acid requirements

  • Investigation of regulatory element functions

Technical implementation challenges:

• Delivery systems:

  • Optimization of transformation methods for B. forsythus

  • Development of phage-based delivery systems

  • Customization of guide RNA design for efficient targeting

• Selection strategies:

  • Marker-free editing using CRISPR interference (CRISPRi)

  • Counterselection methods for scarless genome editing

  • Dual-selection strategies for complex modifications

Combinatorial applications:

• Multi-gene studies:

  • Simultaneous editing of multiple chaperone genes

  • Investigation of functional redundancy

  • Analysis of chaperone networks and hierarchies

• Host-pathogen interaction models:

  • Paired editing of bacterial GroEL and host receptors

  • Creation of humanized mouse models for studying cross-reactivity

  • Development of ex vivo tissue models with edited components

The implementation of CRISPR-Cas9 technology in B. forsythus research would significantly accelerate understanding of GroEL function and potential therapeutic applications by enabling precise genetic manipulations previously unattainable with conventional methods.

How can understanding B. forsythus GroEL inform broader research on bacterial chaperonins?

B. forsythus GroEL research offers unique perspectives that can inform the broader field of bacterial chaperonin biology:

Evolutionary insights:

• Comparative genomics across bacterial phyla to trace chaperonin evolution

• Analysis of selective pressures on GroEL in host-associated vs. free-living bacteria

• Investigation of horizontal gene transfer events affecting chaperonin genes

• Examination of co-evolution between GroEL and GroES/HSP10

Structure-function relationships:

• Identification of species-specific functional adaptations

• Correlation of structural features with pathogenicity

• Analysis of substrate specificity determinants

• Understanding of ATP binding and hydrolysis mechanisms across species

Host-pathogen interface:

• Comparison of immunomodulatory properties across bacterial species

• Examination of molecular mimicry with human HSP60 across diverse pathogens

• Analysis of cross-protective immune responses

• Investigation of chaperonin roles in different disease contexts

Methodological advances:

• Development of novel assays applicable to other bacterial systems

• Optimization of recombinant expression strategies for difficult chaperonins

• Creation of broadly applicable knockout and modification techniques

• Establishment of standardized functional assessment protocols

Therapeutic applications:

• Identification of conserved targets for broad-spectrum antimicrobials

• Development of species-specific targeting strategies

• Vaccine approaches with cross-protection potential

• Diagnostic applications based on conserved and variable regions

The unique ecological niche of B. forsythus in the periodontal pocket provides a valuable model for understanding how chaperonins function in polymicrobial communities and host-associated environments, potentially revealing principles applicable to diverse bacterial systems from environmental microbes to human pathogens .